- Home
- ABEO vs PAYS Comparison
ABEO vs PAYS Comparison
Compare ABEO & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- PAYS
- Stock Information
- Founded
- ABEO 1974
- PAYS 2001
- Country
- ABEO United States
- PAYS United States
- Employees
- ABEO N/A
- PAYS N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- PAYS Business Services
- Sector
- ABEO Health Care
- PAYS Consumer Discretionary
- Exchange
- ABEO Nasdaq
- PAYS Nasdaq
- Market Cap
- ABEO 289.2M
- PAYS 303.3M
- IPO Year
- ABEO 1980
- PAYS 1998
- Fundamental
- Price
- ABEO $5.49
- PAYS $5.57
- Analyst Decision
- ABEO Strong Buy
- PAYS Strong Buy
- Analyst Count
- ABEO 6
- PAYS 4
- Target Price
- ABEO $18.17
- PAYS $8.06
- AVG Volume (30 Days)
- ABEO 1.0M
- PAYS 598.7K
- Earning Date
- ABEO 11-13-2025
- PAYS 11-04-2025
- Dividend Yield
- ABEO N/A
- PAYS N/A
- EPS Growth
- ABEO N/A
- PAYS N/A
- EPS
- ABEO 0.99
- PAYS 0.12
- Revenue
- ABEO $400,000.00
- PAYS $68,539,381.00
- Revenue This Year
- ABEO N/A
- PAYS $35.44
- Revenue Next Year
- ABEO $324.71
- PAYS $21.93
- P/E Ratio
- ABEO $5.69
- PAYS $47.18
- Revenue Growth
- ABEO N/A
- PAYS 27.84
- 52 Week Low
- ABEO $3.93
- PAYS $1.80
- 52 Week High
- ABEO $7.54
- PAYS $8.88
- Technical
- Relative Strength Index (RSI)
- ABEO 44.77
- PAYS 45.46
- Support Level
- ABEO $5.21
- PAYS $5.31
- Resistance Level
- ABEO $5.73
- PAYS $5.81
- Average True Range (ATR)
- ABEO 0.24
- PAYS 0.29
- MACD
- ABEO 0.06
- PAYS -0.04
- Stochastic Oscillator
- ABEO 55.05
- PAYS 22.17
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.